News

ECR has also divested its interest in non-core products like Hylase and Orbivan. Hylase was divested for a one-time payment in January while Orbivan for $500,000 over two

Nordisk’s GLP-1 receptor agonists have shown to leverage Emisphere’s Eligen technology to treat type 2 diabetes. Emisphere president and chief executive officer Alan Rubino said, "The accelerated milestone

Auris will use the Medidata’s Clinical Cloud for randomization and trial supply management (RTSM); electronic data capture (EDC) and clinical data management (CDM) in the forthcoming Phase III

Revenues were $13.5bn for the first quarter ended 31 March 2013, a decrease of 9%, compared to $14.88bn for the same quarter of the previous year. Pfizer chairman

The collaboration will focus on validating epigenetic targets for cancer indications and establishing the drugability of the selected target families. Evotec CEO Dr Werner Lanthaler said, "We are

Plan B One-Step will become the first contraceptive to be available in the Family Planning Aisle in Stores across the country. Teva Women’s Health US Brand Pharmaceuticals vice

Quinapril Tablets USP 5mg, 10mg, 20mg and 40mg is the generic version of Pfizer Pharmaceuticals’ Accupril Tablets 5mg, 10mg, 20mg and 40mg respectively. The product that falls under

The investigational once-daily UMEC, administered using the Ellipta inhaler, is a bronchodilator molecule and a long-acting muscarinic antagonist (LAMA). Application is submitted for the maintenance bronchodilator treatment of

As per the JV, YouCare will market and distribute the nutritional supplements and other natural health and personal care products produced by Thorne Research. Thorne will access the